Investors
Establishing a Foundation for Success
Veracyte is a private molecular diagnostics company founded in 2008. We are backed by leading healthcare investors with numerous years of experience launching successful ventures in molecular diagnostics.
 |
The Domain team brings a unique combination of a highly focused network, excellent reputation, and valuable experience, which has made it one of the top private equity groups involved in the healthcare field. Founded in 1985, the Partners of Domain have nearly 200 combined years of experience in the healthcare/venture capital industries among them, and have been involved in the formation and growth of more than 220 life sciences companies.
|
 |
KPCB is an active venture capital partnership with a large capital base for investment. Since 1972, the company has invested in more than 550 technology companies with an accrued market valuation exceeding $420 billion and employing more than 400,000 people.
|
|
TPG is a leading global investment firm with assets of $50 billion under management across a family of funds. TPG, one of these funds, manages more than $900 million in life science, biotechnology, renewable and medical technology companies.
|
|
Versant Ventures is a leading health care-focused venture capital firm specializing in seed and early-stage investments in medical devices, biotechnology and pharmaceuticals. Versant has funded more than 95 health care companies, with investments totaling more than $1.6 billion under management.
|
Send Veracyte investor related inquiries to investors@veracyte.com.
|
